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Items for this week’s EPI Update include: 
 
• Heat Index goes triple digits: Hints on staying cool 
• Updates on Pertussis Treatment and Prophylaxis 
• Update on ISU Entomology Lyme Disease Project: New Lyme Disease Tick 
Surveillance Postcard 




Heat Index goes triple digits: Hints on staying cool 
At our website <http://www.idph.state.ia.us/> you will find information on how to stay 
cool and healthy during these hot days. You will also find information for those going on 
RAGBRAI on how to beat the heat while biking across Iowa. 
 
  
Updates on Pertussis 
The Centers for Disease Control and Prevention (CDC) guidelines for the “Control of 
Pertussis Outbreaks, 2000” is currently under revision.  The following is updated 
information that should replace material in the 2000 version.  Future updates will be 
posted at <http://www.cdc.gov/nip/publications/guide.htm> as they become available.  
These updates will also be reflected in a revision to the “EPI” Manual pertussis chapter. 
• Treatment and Chemoprophylaxis - The following chart summarizes the 
updated recommendations for use of antibiotics for pertussis treatment and 
prophylaxis. 
 
Table 1. Summary of oral macrolide treatment and chemoprophylaxis for pertussis 
by age group  
Age 
group  
Erythromycin  (14-day course) Clarithromycin  (7-day 
course)  
Azithromycin  (5-day 
course)  
>6 
months    
1-5 
months    
<1 
month  
40-50 mg/kg/day in 4 divided 
doses (maximum 2 gm/day) X 
14 days    As above (estolate 
preparation preferred if 
available)   As above (Use as 
alternate drug in doses above. 
Drug use is associated with 
elevated risk of IHPS)  
15 mg/kg/day in 2 
divided doses (maximum 
500mg/dose) X 7 days   
As above      Not 
recommended (Safety 
data unavailable)  
10mg/kg/day in single 
dose on day 1 then 
5mg/kg/day on Days 2 -
5   10mg/kg/day in 
single daily dose X 5 
days    Preferred drug.  
10mg/kg/day in a single 
daily dose X 5 days.  
Only limited safety 
available.  
 
TMP-SMZ may be used as an alternative agent in patients who are allergic to macrolides, 
who cannot tolerate macrolides, or who are infected, rarely, with a macrolide-resistant 
strain of Bordetella pertussis. The recommended dose in children is trimethoprim 8 
mg/kg/day, sulfamethoxazole 40 mg/kg/day in two divided doses for 14 days. For adults, 
the recommended dose is trimethoprim 320 mg/day, sulfamethoxazole 1,600 mg/day in 
two divided doses for 14 days. Because of the risk of kernicterus, TMP-SMZ should not 
be given to pregnant women, nursing mothers, premature neonates, or infants <2 months 
of age.  
 
Initiating antimicrobial treatment in the patient after three weeks of cough has limited 
benefit except in high-risk cases. 
• Hospitals, Institutions and Clinics  
Health-care workers who have appropriately followed standard and droplet precautions 
(including wearing a surgical mask) during close contact with cases do not require post-
exposure prophylaxis. 
• Use of Pertussis Vaccine After Having Pertussis Disease 
Currently many experts recommend children (especially infants age <12 months) who 
have a history of pertussis disease complete the routine childhood vaccination series for 
pertussis with DTaP.  This is recommended because the duration of protection from 
pertussis disease is unknown and pertussis can be difficult to confirm.  At least one study 
found that infants (age <12months) may have a suboptimal immune response following 
pertussis disease. 
 
• Recommendations for Use of Tdap and Td vaccines among Adolescents 
Final national recommendations on use of these new vaccines are pending and will be 
posted in the Friday Epi-Update when available.  Draft recommendations are as follows: 
• Tdap should replace Td for all 11 and 12 year olds.   
• Those ages 13-18 years who have not yet received a Td booster, should 
receive Tdap in place of Td.   
• Adolescents ages 11-18 who have received Td are encouraged to receive a 
single dose of Tdap to provide protection against pertussis if they have 
completed their recommended childhood DTaP vaccination series, once 
five years have elapsed to limit the risk of local reactions.   
 
Update on ISU Entomology Lyme disease project: New Lyme disease tick 
surveillance postcard 
Iowa State University, Department of Entomology, in partnership with Iowa Department 
of Public Health, has conducted a Lyme disease tick surveillance project for over 15 
years (<http://www.ent.iastate.edu/lds/lds.html>).  This project has been and continues to 
be very valuable for knowing what species of ticks occur in Iowa and where they occur.  
Previously, ticks that were submitted to ISU and were identified as deer ticks were tested 
for the organism that causes Lyme disease, and this result was reported to the individual 
who submitted the tick.  Based on past and current research, in addition to 
recommendations by the Infectious Disease Society of America (IDSA), ISU 
Entomology will no longer report the results of testing deer ticks for Borrelia burgdorferi 
to the submitter of the tick. The rational being, people were using this result to 
inappropriately determine need for treatment. Testing deer ticks for Borrelia burgdorferi 
will continue for research purposes only. 
 
If you find a tick attached to yourself and would like to have the specie of tick identified, 
mail the tick to Lyme Disease Project, Department of Entomology, 440 Science II, Iowa 
State University, Ames, IA 50011-3222.  Place the tick in a sealed plastic bag with tissue 
paper and 2-3 drops of water, and mail in a standard envelope; please include your name 
and address; geographic location where you found the tick; and whether it was attached 
or not and to what (e.g., you? your dog?).   You will receive a postcard in the mail that 
identifies the species of the tick. 
  
Although Lyme disease is the most common tick-borne disease reported in Iowa, only 49 
confirmed cases were reported last year.  The percentage of deer ticks in Iowa estimated 
to be infected with the organism that causes Lyme disease (Borrelia burgdorferi) is 
around eight to 10 percent.  The chance of being infected with the organism is actually 
much lower and is actually less than three percent.  Research shows that the deer tick 
must be attached for more than 24 hours (typically 48 to 72 hours) to transmit the 
organism.  Additionally, the nymph stage (pre-adults) of deer ticks is more likely to 
transmit the organism than adult deer ticks.  Because feeding nymphs are rarely noticed 
due to their small size, they are more likely to feed for at least 48 to 72 hours.  The 
Infectious Disease Society of America (IDSA) does not recommend giving antibiotics 
just because someone has been bitten by a tick.  Treatment by a medical provider should 
not be based on the results of testing deer ticks but rather on evaluation of the patient. 
 
The recommendation by CDC, IFDSA and IDPH for persons who find ticks attached to 
them is to watch for fever or a rash at the site of attachment for 30 days.  If these 
symptoms occur, they should see their medical provider to be assessed for Lyme disease 
or one of the other diseases that can be transmitted by ticks (for example, human 
granulocytic ehrlichiosis, Rocky Mountain spotted fever or babesiosis of which the first 
two are known to occur in Iowa). 
 
For the IDSA’s guidelines on treatment of Lyme disease, please go to:  
<<http://www.journals.uchicago.edu/CID/journal/issues/v31nS1/000342/000342.web.pdf
>>  




CDC 2005 recommendations on Prevention and Control of Influenza  
You might not be thinking of Influenza yet, but CDC is.  Here are three of the principle 
changes/recent updates are: 
• ACIP recommends that persons with any condition (e.g., cognitive dysfunction, 
spinal cord injuries, seizure disorders, or other neuromuscular disorders) that can 
compromise respiratory function or the handling of respiratory secretions or that 
can increase the risk for aspiration be vaccinated against influenza (see “Target 
Groups for Vaccination”).  
• ACIP emphasizes that all health-care workers should be vaccinated against 
influenza annually, and facilities that employ health-care workers are strongly 
encouraged to provide vaccine to workers by using approaches that maximize 
immunization rates.  
• Use of both available vaccines (inactivated and LAIV) is encouraged for eligible 
persons every influenza season, especially persons in recommended target groups. 
During periods when inactivated vaccine is in short supply, use of LAIV is 
especially encouraged when feasible for eligible persons (including health-care 
workers) because use of LAIV by these persons might considerably increase 
availability of inactivated vaccine for persons in groups at high risk.  
For the entire MMWR go to 
<http://www.cdc.gov/mmwr/preview/mmwrhtml/rr54e713a1.htm> and 
<http://www.cdc.gov/mmwr/preview/mmwrhtml/rr54e713e1.htm>.  
Meetings:   
 
• Save The Date! 
The annual Iowa HIV/AIDS Conference will be held October 11 & 12 in Des 
Moines.  
 
